U.S. Physical Therapy (USPH)
(Real Time Quote from BATS)
$72.76 USD
+0.74 (1.03%)
Updated Aug 6, 2025 03:39 PM ET
After-Market: $73.01 +0.25 (0.34%) 4:06 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
USPH 72.76 +0.74(1.03%)
Will USPH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for USPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USPH
ELAN vs. USPH: Which Stock Is the Better Value Option?
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
USPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
ELAN vs. USPH: Which Stock Should Value Investors Buy Now?
Is the Options Market Predicting a Spike in U.S. Physical Therapy Stock?
U.S. Physical Therapy (USPH) Beats Q1 Earnings Estimates (Revised)
Other News for USPH
Earnings Scheduled For August 6, 2025
US Physical Therapy Inc (USPH) Q2 2025: Everything You Need to Know Ahead of Earnings
USPH Acquires Stake in Growing Physical Therapy Practice
U.S. Physical Therapy Announces the Acquisition of a Three-Clinic Physical Therapy Practice | ...
U.S. Physical Therapy acquires physical therapy practice, terms undisclosed